Autolus Therapeutics plc (AUTL) Operating cash flow 2016–2025
Autolus Therapeutics plc (AUTL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$283.6MFY2025 · since FY2016: -$9.8M → -$283.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$283.6M | -37.5% |
| FY2024 | -$206.3M | -41.7% |
| FY2023 | -$145.6M | -29.6% |
| FY2022 | -$112.3M | +4.7% |
| FY2021 | -$117.9M | -0.1% |
| FY2020 | -$117.8M | -16.0% |
| FY2019 | -$101.5M | -221.8% |
| FY2018 | -$31.5M | -92.8% |
| FY2017 | -$16.4M | -66.1% |
| FY2016 | -$9.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice